This section of the website provides information for existing and potential investors in Vectura Group plc including financial reports, an interactive share price chart and updates on our latest news.

Why invest in us?

Vectura's focused application of technology, know-how and expertise has demonstrated that the potential for new inhaled pharmaceuticals with real therapeutic and commercial value can be realised.

Latest performance

Share price chart

Reports and presentations

Vectura Group plc – Preliminary Results for year ended 31 March 2015

ROTH 27th Annual Conference 2015, California

Barclays Global Healthcare Conference, Miami

Latest regulatory news

Share price
Upcoming event
24 Sep 2015

Annual General Meeting

17 Nov 2015

Interim results for six months ending 30 September 2015